ReproCELL Incorporated (TYO:4978)

Market Cap	11.69B -11.8%
Revenue (ttm)	2.23B -25.0%
Net Income	-591.00M
EPS	-6.24
Shares Out	95.03M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	419,200
Open	124.00
Previous Close	123.00
Day's Range	121.00 - 128.00
52-Week Range	122.00 - 242.00
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	May 14, 2026

About ReproCELL

ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 99
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4978